GLH.AU · Global Health Limited

-

Please sign in to comment on GLH.AU

1 Comment

Admin

4 years, 1 month ago

Global Health Limited is currently in a long term uptrend where the price is trading 3.6% above its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.

Global Health Limited's total revenue rose by 13.6% to $3M since the same quarter in the previous year.

Its net income has increased by 89.7% to $-52K since the same quarter in the previous year.

Finally, its free cash flow grew by 98.5% to $-9K since the same quarter in the previous year.

Based on the above factors, Global Health Limited gets an overall score of 5/5.

ISIN	AU000000GLH2
Exchange	AU
CurrencyCode	AUD
Sector	Healthcare
Industry	Health Information Services

Target Price	23.616
Market Cap	5M
PE Ratio	None
Beta	-0.14
Dividend Yield	None

ABOUT

Global Health Limited

Global Health Limited provides digital health solutions for the healthcare industry in Australia. The company offers saas and software applications for electronic medical records, patient administration systems, practice management systems, clinical records, secure connectivity, patient engagement platforms, and consumer health records. It is also involved in the development, sale, and support of the application software for the healthcare sector; and development of system integration software that enables data to be exchanged within an enterprise. The company sells its products under the MasterCare, PrimaryClinic, HotHealth, ReferralNet, and Lifecard brands. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.

GLH.AU · Global Health Limited

-

Global Health Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Global Health Limited using a moving average strategy